Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-011639
Filing Date
2022-03-18
Accepted
2022-03-18 19:56:19
Documents
1
Period of Report
2022-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13840
  Complete submission text file 0000899243-22-011639.txt   15342
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CEREVEL THERAPEUTICS, INC. 51 ASHTOR PLACE NEW YORK NY 10003
Business Address
Renger John (Reporting) CIK: 0001830363 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 22753948